Are the procedures for treating Fuchs endothelial dystrophy considered corneal graft surgeries?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, procedures for treating Fuchs endothelial dystrophy are corneal graft surgeries.

All surgical treatments for Fuchs endothelial dystrophy involve transplantation of donor corneal tissue (grafts), making them definitively graft surgeries. 1

Types of Corneal Graft Surgeries for Fuchs Dystrophy

The evidence clearly demonstrates that 95% of Fuchs dystrophy patients are treated with endothelial keratoplasty (EK), which encompasses several graft-based techniques 1:

Primary Graft Procedures:

  • DMEK (Descemet's Membrane Endothelial Keratoplasty): Replaces diseased Descemet's membrane/endothelium with healthy donor Descemet's membrane/endothelium 1

  • DSAEK/DSEK (Descemet's Stripping Automated/Endothelial Keratoplasty): Replaces recipient Descemet's membrane with a thin donor lenticule that includes posterior stroma and Descemet's membrane 1

  • PK (Penetrating Keratoplasty): Full-thickness corneal graft replacement 1

  • DLEK (Deep Lamellar Endothelial Keratoplasty): Removes and replaces posterior stromal/Descemet's membrane lenticule with donor tissue 1

Key Evidence Supporting Graft Nature

The guideline explicitly refers to these procedures using terminology that confirms their graft status 1:

  • "Graft decentration or dislocation"
  • "Graft rejection" rates (ranging from 0-22% depending on technique)
  • "Graft failure rate at 5 years"
  • "Donor tissue preparation"
  • "Donor lenticule"
  • Eye Bank Association data tracking "keratoplasties" (graft surgeries)

All these procedures require donor corneal tissue from eye banks and carry risks inherent to transplantation, including graft rejection, graft failure, and the need for immunosuppression in some cases 1.

The only potential exception mentioned is experimental Descemet membrane transplantation (DMT) using acellular tissue, but this remains investigational 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.